Trial
NCT05689359
Evaluation of Hydroxychloroquine to Prevent CIPN
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
—
Condition
Breast Cancer
Intervention
Hydroxychloroquine
Why stopped
Per Principal Investigator, it is not feasible to move forward with this trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-08